PGxAI and Lean, Backed by PIF, Unite to Transform Precision Medicine and Genomics in Saudi Arabia
In a landmark move reinforcing Saudi Arabia’s position at the forefront of healthcare innovation, PGxAI a portfolio company of Najashi Holding, has signed a Memorandum of Understanding with Lean Business Services, a subsidiary of the Public Investment Fund, during the Global Health Exhibition 2025. This strategic partnership marks a significant step toward advancing precision medicine and genomics through artificial intelligence, aligning with the Kingdom’s ambition to lead in next-generation healthcare technologies. The collaboration will focus on integrating advanced AI-driven solutions into clinical and research environments, enabling faster, more accurate, and highly personalized healthcare outcomes. At the heart of this collaboration is PGxAI’s pioneering technology, developed in Silicon Valley and rooted in cutting-edge research. The company has built an advanced AI-powered multiomics platform capable of analyzing complex genomic data with unprecedented speed and accuracy. What traditionally required weeks of laboratory processing and analysis can now be achieved in a matter of minutes, dramatically accelerating the detection of genetic mutations and enabling early cancer diagnosis. PGxAI’s suite of solutions spans pharmacogenomics, carrier screening, and early disease detection, offering healthcare providers powerful tools to tailor treatments to individual genetic profiles. By transforming vast amounts of biological data into actionable clinical insights, these innovations are redefining how precision medicine is practiced moving from reactive treatment to proactive, preventive care. Through this partnership, Lean will play a critical role in enabling the integration and scalability of PGxAI’s technologies across the Kingdom’s healthcare infrastructure. Backed by PIF, Lean’s digital health capabilities and national reach will support the localization of these advanced solutions, ensuring they are effectively embedded within Saudi Arabia’s healthcare ecosystem. This collaboration not only highlights Najashi Holding’s commitment to investing in transformative healthcare technologies but also underscores its role in driving localization and knowledge transfer within the Kingdom. By supporting PGxAI’s expansion and facilitating high-impact partnerships, Najashi is actively contributing to building a robust genomics sector in Saudi Arabia. Aligned with the goals of Saudi Vision 2030, this partnership represents a powerful convergence of innovation, investment, and national strategy. It sets the stage for a new era of intelligent, data-driven healthcare—one that enhances patient outcomes, advances scientific discovery, and positions Saudi Arabia as a global leader in precision medicine.
Launch of Sukuk Seha Platform to Advance Healthcare Financing Solutions
In a significant step toward strengthening Saudi Arabia’s healthcare financing ecosystem, the “Seha Sukuk” platform has been officially launched, marking a new era of innovative, Shariah-compliant financial solutions dedicated to the healthcare and biotechnology sectors. The announcement was made during the Global Health Exhibition 2025, in the presence of His Excellency Fahad Al-Jalajel, Minister of Health. The platform was introduced through a strategic collaboration with Esnad Financial Company, following approval from the Capital Market Authority. Seha Sukuk has been developed as a specialized platform designed to address the evolving financing needs of healthcare providers and biotechnology companies across the Kingdom. By offering tailored sukuk-based solutions, the platform enables access to capital in a manner that aligns with Islamic finance principles while supporting sector growth and sustainability. The initiative aims to activate and expand investment in both healthcare and biotechnology, key pillars of Saudi Arabia’s future economic diversification. It directly aligns with the ambitions of Saudi Vision 2030 and supports the National Biotechnology Strategy, which targets biotechnology contributing 3% to the Kingdom’s GDP by 2040. Through this platform, Seha Sukuk is positioned to play a vital role in enabling private sector participation and unlocking new funding channels for high-impact projects. It will empower institutions to scale operations, invest in innovation, and enhance service delivery across the healthcare value chain. The launch also reinforces the growing importance of public-private collaboration in achieving national transformation goals. By introducing innovative financial instruments and strengthening market accessibility, Seha Sukuk contributes to the advancement of the Health Sector Transformation Program. This milestone underscores a strong commitment to building a resilient, future-ready healthcare ecosystem—one driven by innovation, supported by robust financial infrastructure, and aligned with the Kingdom’s long-term vision for sustainable growth.
Seha Invest and Value Capital Launch SAR 500 Million Fund to Transform Healthcare and Biotech Investment
In a landmark moment for Saudi Arabia’s healthcare investment landscape, a new chapter has been written with the launch of a SAR 500 million direct financing fund dedicated to the healthcare and biotechnology sectors. Today, Seha Invest, in strategic partnership with Value Capital, officially announced the establishment of this pioneering fund. The launch was celebrated in the presence of Royal Highnesses, Excellencies, and an esteemed group of leaders from the healthcare and financial sectors, highlighting the significance of this initiative at a national level. This fund represents a bold step forward in accelerating investment across two of the Kingdom’s most vital and high-growth sectors. Designed to provide direct financing solutions, it will empower healthcare providers, biotech innovators, and emerging companies with the capital needed to scale, innovate, and deliver impactful solutions. By bridging funding gaps and enabling access to flexible financing, the fund aims to unlock new opportunities and drive sustainable sector growth. Aligned with the ambitions of Saudi Vision 2030, the initiative directly supports key national priorities, including the Financial Sector Development Program and the Health Sector Transformation Program. Together, these efforts are focused on strengthening the Kingdom’s financial ecosystem, enhancing healthcare quality, and positioning Saudi Arabia as a regional hub for life sciences and biotechnology. Beyond capital deployment, the fund is set to play a transformative role in enabling innovation, advancing localization efforts, and fostering a robust national biotech ecosystem. It reflects a shared commitment to not only support existing healthcare institutions but also to nurture next-generation companies that will define the future of medicine in the Kingdom. At its core, this initiative is driven by a strong belief: investing in healthcare is an investment in the future. Through this collaboration, Seha Invest and Value Capital are laying the foundation for a more resilient, innovative, and sustainable healthcare sector, one that will continue to evolve and thrive for generations to come.
Inauguration Ceremony of Seha Invest Marks a Milestone in Healthcare Investment
Najashi Holding proudly celebrated the inauguration of Seha Invest, marking a significant step forward in its commitment to advancing the Kingdom’s healthcare investment landscape. The ceremony was attended by a distinguished group of Royal Highnesses, Excellencies, and prominent business leaders from across the healthcare sector, reflecting the importance of this initiative at both national and industry levels. Seha Invest has been established as a dedicated investment platform focused on unlocking high-impact opportunities within healthcare and biotechnology. The platform aims to accelerate the development of innovative medical solutions, enhance local capabilities, and support the growth of a resilient and sustainable healthcare ecosystem in Saudi Arabia. By fostering strategic partnerships and enabling capital deployment into promising ventures, Seha Invest is positioned to play a pivotal role in shaping the future of healthcare in the Kingdom. This milestone aligns closely with Najashi Holding’s broader vision to drive meaningful investments in the healthcare sector. As a family office committed to long-term value creation, Najashi Holding continues to prioritize initiatives that support localization, promote knowledge transfer, and strengthen domestic industries. Its efforts are focused on identifying transformative opportunities that contribute to improved healthcare outcomes and economic diversification. The launch of Seha Invest also reinforces Najashi Holding’s commitment to supporting the objectives of Saudi Vision 2030. By investing in healthcare innovation, empowering local talent, and building strategic alliances, the company is contributing to the Kingdom’s ambition to become a regional hub for advanced healthcare and life sciences. Through initiatives like Seha Invest, Najashi Holding reaffirms its role as a catalyst for growth, innovation, and sustainable development in one of the Kingdom’s most vital sectors.
Najashi Holding Showcases Localization Vision at Leading Global and Regional Events
Najashi Holding has actively participated in a series of prominent local and international conferences, reinforcing its role as a forward-looking family office committed to advancing investment and localization initiatives across the healthcare and biotechnology sectors. Through its presence at these high-level gatherings, Najashi Holding highlighted its strategic efforts to drive sustainable growth by fostering local capabilities, supporting knowledge transfer, and enabling innovation within the Kingdom’s rapidly evolving life sciences ecosystem. The company’s participation reflects its broader mission to contribute to national priorities by strengthening domestic value chains and accelerating the development of cutting-edge healthcare solutions. Engagements at these events facilitated meaningful dialogue with global industry leaders, policymakers, and innovators. Discussions focused on the opportunities and challenges shaping Saudi Arabia’s biotechnology and healthcare landscape, with particular emphasis on regulatory advancement, talent development, research collaboration, and investment readiness. These conversations underscored the Kingdom’s strong potential to emerge as a regional hub for biotechnology and advanced healthcare. Najashi Holding emphasized the importance of strategic partnerships and cross-border collaboration in unlocking transformative growth, driving scientific breakthroughs, and improving patient outcomes. Building on these insights, Najashi Holding remains committed to expanding its investment footprint, supporting localization strategies, and contributing to a resilient, innovation-driven healthcare ecosystem aligned with Saudi Vision 2030.
From Silicon Valley to Saudi Arabia: AI Meets Multiomics, Powering the Future of Healthcare
When you combine the power of AI with real-world data, you do not just get innovation; you ignite a revolution in how healthcare decisions are made. PGxAI, a Silicon Valley based company, has developed a proprietary AI model that unlocks new insights in genomics and multiomics, bringing us closer to a future where diagnostics are faster, smarter, and truly personalized. What excites us most is the impact. PGxAI, originated within stanford, is advancing solutions in pharmacogenomics, carrier screening, and early cancer detection. With AI-driven multiomics analysis, results that once took weeks can now be delivered in minutes. These are life-saving tools that will reshape the way we approach Precision medicine. By investing in PGxAI and localizing their breakthrough technology in Saudi Arabia, we are taking a bold step to accelerate the Kingdom’s Biotechnology Strategy and Vision 2030.